Top compounds associated with response to MYBL2


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib CCLE pan-cancer AAC -0.001 1
mRNA narciclasine CTRPv2 pan-cancer AAC -0.00071 1
mRNA SR1001 CTRPv2 pan-cancer AAC 0.00074 1
mRNA BRD-K02251932 CTRPv2 pan-cancer AAC -0.00033 1
mRNA sitagliptin CTRPv2 pan-cancer AAC 0.0006 1
mRNA CP466722 GDSC1000 pan-cancer AAC 2.2e-05 1
Download CSV